Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Outcome for Outcome Of Board Meeting Dated 30Th January 2023

 This has reference to the meeting of Board of Directors held on 30th January 2023 inter alia considered and approved the Unaudited Financial Results for the period ended on 31st December 2022 along with Limited Review report. Unaudited Financial Results for the period ended on 31st December 2022 along with Limited Review report are enclosed herewith. Meeting commenced at 04:30 pm and concluded at 07.48 pm. Kindly take the above information on your record.
30-01-2023
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Board Meeting To Be Held On 30Th January 2023

 VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 ,inter alia, to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and period ended on 31st December 2022. 2. Any other business with the permission of Chair.
19-01-2023
Bigul

VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, we enclose herewith Confirmation Certificate received from our Registrar & Transfer Agent, M/s. Link Intime India Pvt Ltd. for the quarter ended on 31st December 2022.
10-01-2023
Bigul

VENUS REMEDIES LTD. - 526953 - Closure of Trading Window

 Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform that the trading window for dealing in equity shares of the Company shall remain closed for all Designated Persons of the Company, as defined under the said Regulations, from January 1, 2023, till 48 hours from the declaration of the Unaudited Financial Results for the quarter ending on December 31, 2022.
29-12-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper publication of Financial Results.
15-11-2022
Bigul

VENUS REMEDIES LTD. - 526953 - For The Quarter And Half Year Ended On 30.09.2022

 For the quarter and half year ended on 30.09.2022
12-11-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Outcome for Outcome Of Board Meeting

 This has reference to the meeting of Board of Directors held on 12th November 2022 inter alia considered and approved the Unaudited Financial Results for the half year and quarter ended on 30th September 2022 along with Limited Review report. Unaudited Financial Results for the half year and quarter ended on 30th September 2022 along with Limited Review report are enclosed herewith. Meeting concluded at 07:40 pm. Kindly take the above information on your record
12-11-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Board Of Directors Meeting Is Scheduled To Be Held On 12Th November 2022.

 VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 12th November 2022 inter alia: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the half year and quarter ended on 30th September 2022. 2. Any other business with the permission of Chair. This is to inform you that the meeting of Board of Directors is scheduled to be held on 12th November 2022 inter alia: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the half year and quarter ended on 30th September 2022. 2. Any other business with the permission of Chair.
02-11-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Board Of Directors Meeting Is Scheduled To Be Held On 12Th November 2022.

 VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 12th November 2022 inter alia: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the half year and quarter ended on 30th September 2022. 2. Any other business with the permission of Chair.
02-11-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Statement Of Investor Complaints For The Quarter Ended September 2022 (Revised)

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 01082 Name of the Signatory :- NehaDesignation :- Company Secretary and Compliance Officer
14-10-2022
Next Page
Close

Let's Open Free Demat Account